Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland, School of Medicine, 22 S. Greene St, Baltimore, MD, 21202, USA.
Skeletal Radiol. 2022 Jan;51(1):11-15. doi: 10.1007/s00256-021-03755-2. Epub 2021 Mar 6.
Structured reporting systems have been developed for many organ systems and disease processes beginning with BI-RADS in 1993. Numerous reports indicate that referring health care providers prefer structured reports. Reducing variability of reports from one radiologist to another helps referring physician and patient confidence. Changing radiologists practice habits from completely free text to structured reports can be met with some resistance, but most radiologists quickly find that structured reports make their job easier. Whole-body MR studies are recommended as first-line imaging, by the International Myeloma Working Group (IMWG), for all patients with suspected diagnosis of asymptomatic myeloma and/or initial diagnosis of solitary plasmacytoma. Whole-body MR imaging (WBMRI) has been shown to have equal or greater sensitivity and specificity compared to PET/CT for detection of bone marrow involvement. Changing to WBMRI from other imaging modalities can be difficult for referring providers. Patient acceptance is high. MY-RADS is for myeloma patients who have WBMRI studies done. The intent of the system is to promote uniformity in MR imaging acquisition, diagnostic criteria, and response assessment and to diminish differences in the subsequent interpretation and reporting. A secondary benefit is a report template that provides a guide for interpretation for radiologists who may not have previously dictated these difficult studies. The characterization of bone marrow abnormalities in myeloma patients usually is fairly straightforward. To date, there is no standardized scoring or risk stratification of abnormalities nor is there an imaging atlas of abnormalities.
从 1993 年的 BI-RADS 开始，许多器官系统和疾病过程都已经开发了结构化报告系统。许多报告表明，转诊医疗服务提供者更喜欢结构化报告。减少不同放射科医生之间报告的变异性有助于提高转诊医生和患者的信心。将放射科医生的实践习惯从完全自由文本转变为结构化报告可能会遇到一些阻力，但大多数放射科医生很快发现结构化报告使他们的工作更轻松。国际骨髓瘤工作组（IMWG）建议对所有疑似无症状骨髓瘤和/或孤立性浆细胞瘤初始诊断的患者进行全身磁共振（MR）研究作为一线成像。全身 MR 成像（WBMRI）在检测骨髓受累方面与 PET/CT 相比具有同等或更高的敏感性和特异性。对于转诊提供者来说，从其他成像方式转换为 WBMRI 可能会很困难。患者接受度很高。MY-RADS 适用于接受过 WBMRI 检查的骨髓瘤患者。该系统的目的是促进 MR 成像采集、诊断标准和反应评估的一致性，并减少后续解释和报告中的差异。次要好处是为可能以前没有描述过这些困难研究的放射科医生提供解释指南的报告模板。骨髓瘤患者骨髓异常的特征通常相当简单。迄今为止，还没有对异常进行标准化评分或风险分层，也没有异常的成像图谱。
